# BioDerm

BioDerm is an Asset Manager based in Largo, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Largo, United States
- **Region:** North America
- **Address:** Largo, FL, United States
- **Founded:** 1999
- **Assets under management:** Undisclosed
- **Website:** bioderm.com
- **LinkedIn:** https://www.linkedin.com/company/bioderminc

## Regulatory record

- **Reports private funds:** No

## About

Bioderm is a healthcare provider founded in 1999 in Bucharest, Romania. It offers diagnostic and treatment services for various skin conditions using technologies like laser treatments, light therapy, and skin cancer diagnostic equipment. Bioderm serves individuals requiring dermatological care and treatments.

## Sectors

- Digital Health
- Healthcare Services

## Questions

### What is BioDerm's investment mandate?

BioDerm acquires majority stakes in mature, cash-flowing medical-device product lines within urology, continence care, wound care, and diabetes supplies. The firm targets products with established Medicare and private-payer reimbursement codes where clinician habit creates durable purchasing patterns. It does not invest in early-stage devices, pharmaceuticals, or capital equipment. Acquisitions are funded from operating profits rather than outside limited partners.

### How does BioDerm source acquisition targets?

BioDerm identifies targets through its clinical training network and direct relationships with hospital supply-chain administrators. The firm's nurse-education programs generate visibility into which product lines are gaining clinician adoption before those products appear in formal sell-side processes. This embedded clinical presence functions as a proprietary sourcing channel distinct from intermediated auctions.

### Does BioDerm take outside capital or co-invest alongside financial sponsors?

There is no public record of BioDerm accepting limited-partner commitments or co-investing alongside private equity funds. The firm's acquisition activity is funded entirely from the cash flows of its core manufacturing business, which gives it the ability to hold assets indefinitely without a mandated exit timeline.

### What is BioDerm's geographic concentration?

BioDerm's manufacturing, distribution, and acquisition activity is concentrated in the United States, with a particular emphasis on the Southeastern region. Its products are distributed nationally through durable medical equipment suppliers, home-health agencies, and Veterans Health Administration procurement contracts. The firm has not disclosed international operations or offshore manufacturing.

## Related profiles

- [New Jersey Commission on Science & Technology](https://altss.com/profile/new-jersey-commission-on-science-and-technology)
- [Colvest Holdings](https://altss.com/profile/colvest-holdings-inc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/bioderm

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology